title: [Maintenance therapy with biologic agents for Crohn's disease: impact of scheduled maintenance therapy with infliximab].
authors.affiliation: Division of Gastroenterology, Tohoku University Graduate School of Medicine, Japan. kento@med.tohoku.ac.jp
authors.forename: Katsuya
authors.initials: K
authors.lastname: Endo
authors.forename: Hisashi
authors.initials: H
authors.lastname: Shiga
authors.forename: Yoichi
authors.initials: Y
authors.lastname: Kakuta
authors.forename: Seiichi
authors.initials: S
authors.lastname: Takahashi
authors.forename: Yoshitaka
authors.initials: Y
authors.lastname: Kinouchi
authors.forename: Tooru
authors.initials: T
authors.lastname: Shimosegawa
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D003424:Crohn Disease / Q000188:drug therapy*; D005260:Female; D005765:Gastrointestinal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D000069285:Infliximab; D008297:Male
chemical_list: D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D000069285:Infliximab